Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope - Trial NCT05873387
Access comprehensive clinical trial information for NCT05873387 through Pure Global AI's free database. This phase not specified trial is sponsored by Eko Devices, Inc. and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 2420 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Eko Devices, Inc.
Timeline & Enrollment
N/A
Jul 12, 2023
Dec 01, 2025
Primary Outcome
Build a database of matched ECG/PCG recordings labeled against RHCs and echocardiograms,Develop and clinically test a deep learning algorithm that can detect PH and stratify its severity
Summary
The major goal of the study is to determine whether phonocardiography (using the Eko DUO
 stethoscope which can capture a three lead ECG reading) can present features that relate to
 the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and
 therefore have a potential to assist the provider to suspect PH.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05873387
Device Trial